140 related articles for article (PubMed ID: 36109419)
21. Primary immunodeficiency update and newborn screening.
Amado MC
Mo Med; 2011; 108(5):350-3. PubMed ID: 22073493
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study.
Audrain M; Thomas C; Mirallie S; Bourgeois N; Sebille V; Rabetrano H; Durand-Zaleski I; Boisson R; Persyn M; Pierres C; Mahlaoui N; Fischer A
Clin Immunol; 2014 Feb; 150(2):137-9. PubMed ID: 24412905
[No Abstract] [Full Text] [Related]
23. Limitation of TREC-based newborn screening for ZAP70 Severe Combined Immunodeficiency.
Grazioli S; Bennett M; Hildebrand KJ; Vallance H; Turvey SE; Junker AK
Clin Immunol; 2014 Jul; 153(1):209-10. PubMed ID: 24797280
[No Abstract] [Full Text] [Related]
24. Newborn Screening for Severe Combined Immunodeficiency in the United States: Lessons Learned.
Dorsey MJ; Puck JM
Immunol Allergy Clin North Am; 2019 Feb; 39(1):1-11. PubMed ID: 30466767
[TBL] [Abstract][Full Text] [Related]
25. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases.
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Jaing TH; Shih YF; Tseng TY; Lin YL
Ann Med; 2014 Nov; 46(7):555-65. PubMed ID: 25109505
[TBL] [Abstract][Full Text] [Related]
26. The case for newborn screening for severe combined immunodeficiency and related disorders.
Puck JM
Ann N Y Acad Sci; 2011 Dec; 1246():108-17. PubMed ID: 22236435
[TBL] [Abstract][Full Text] [Related]
27. Case report:
Äng C; Zetterström RH; Ramme K; Axelsen E; Marits P; Sundin M
Front Immunol; 2023; 14():1257581. PubMed ID: 37771582
[TBL] [Abstract][Full Text] [Related]
28. Newborn Screening for Severe Combined Immunodeficiency.
Routes J; Verbsky J
Curr Allergy Asthma Rep; 2018 May; 18(6):34. PubMed ID: 29749587
[TBL] [Abstract][Full Text] [Related]
29. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
[TBL] [Abstract][Full Text] [Related]
30. Normal neonatal TREC and KREC levels in early onset juvenile idiopathic arthritis.
Gudmundsdottir JA; Thorgeirsdottir S; Lundbäck V; Göngrich C; Lingman Framme J; Kindgren E; Rydenman K; Ludviksson BR; Bjarnadottir H; Runarsdottir S; Nilsson S; Zetterström RH; Ekwall O; Lindgren S
Clin Immunol; 2023 Apr; 249():109277. PubMed ID: 36878420
[TBL] [Abstract][Full Text] [Related]
31. Newborn Screening for Severe Combined Immunodeficiency.
Taki M; Miah T; Secord E
Immunol Allergy Clin North Am; 2021 Nov; 41(4):543-553. PubMed ID: 34602227
[TBL] [Abstract][Full Text] [Related]
32. Causes of low neonatal T-cell receptor excision circles: A systematic review.
Mauracher AA; Pagliarulo F; Faes L; Vavassori S; Güngör T; Bachmann LM; Pachlopnik Schmid J
J Allergy Clin Immunol Pract; 2017; 5(5):1457-1460.e22. PubMed ID: 28359806
[No Abstract] [Full Text] [Related]
33. Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia.
Scott EM; Chandra S; Li J; Robinette ED; Brown MF; Wenger OK
J Clin Immunol; 2020 Feb; 40(2):321-328. PubMed ID: 31903518
[TBL] [Abstract][Full Text] [Related]
34. Abnormal T-Cell Receptor Excision Circle Newborn Screen: What Next?
Prince BT; Routes JM
J Allergy Clin Immunol Pract; 2018; 6(1):318-319. PubMed ID: 29310763
[No Abstract] [Full Text] [Related]
35. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
Richards S; Pitt J; Choo S
J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
[TBL] [Abstract][Full Text] [Related]
36. Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency.
Blom M; Pico-Knijnenburg I; Imholz S; Vissers L; Schulze J; Werner J; Bredius R; van der Burg M
J Clin Immunol; 2021 Nov; 41(8):1762-1773. PubMed ID: 34370170
[TBL] [Abstract][Full Text] [Related]
37. Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies.
Serana F; Chiarini M; Zanotti C; Sottini A; Bertoli D; Bosio A; Caimi L; Imberti L
J Transl Med; 2013 May; 11():119. PubMed ID: 23656963
[TBL] [Abstract][Full Text] [Related]
38. Chromosome 1q23.3q31.1 deletion associated with decreased newborn screening of T cell receptor rearrangement circles (TRECs).
Lee JS; Becker BA; Kirby A; Knutsen AP
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):125-126. PubMed ID: 29653236
[No Abstract] [Full Text] [Related]
39. Defining combined immunodeficiency.
Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
[TBL] [Abstract][Full Text] [Related]
40. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
